dc.contributor.author | Veronica M Masila, Albert J Ndakala, Robert Byamukama, Jacob O Midiwo, Rahab W Kamau, Mei Wang, Mallika Kumarihamy, Jianping Zhao, Matthias Heydreich, Ilias Muhammad | |
dc.date.accessioned | 2022-06-22T11:12:28Z | |
dc.date.available | 2022-06-22T11:12:28Z | |
dc.date.issued | 2021-11 | |
dc.identifier.uri | https://repository.maseno.ac.ke/handle/123456789/5291 | |
dc.description | https://doi.org/10.1080/14786419.2020.1716346 | en_US |
dc.description.abstract | In an attempt to synthesize carvotacetone analogues, new 3-O-benzyl-carvotacetone (10) and previously reported 3-hydroxy-2-isopropyl-5-methyl-p-benzoquinone (11) were synthesized from piperitone (7). In this work, we describe the synthesis of 10 and other analogues from 7. Luche reduction of 7 to cis-piperitol (8), followed by benzylation yielded 3-O-benzyl-piperitol (9). Riley oxidation of 9 afforded corresponding ketone 10, 11 and 3-benzyloxy-4-isopropylcyclohex-1-enecarbaldehyde (12). Structures of these compounds were determined based on NMR, IR and LC-MS spectral data. Compound 11, exhibited antiplasmodial activities against chloroquine-sensitive (D6) and resistant (W2) strains of Plasmodium falciparum with IC50 values of 0.697 and 0.653 µg/mL, respectively. In addition, compound 11 was active against Cryptococcus neoformans with an IC50 value of 3.11 µg/mL, compared to reference standard fluconazole (IC50 value of 1.87 µg/mL), while 10 and 12 were inactive against both organisms. This is the first report of the antiplasmodial and anticryptococcal activity of compound 11. | en_US |
dc.publisher | Taylor & Francis | en_US |
dc.subject | Piperitone;Riley oxidation;3-hydroxy-2-isopropyl-5-methyl-p-benzoquinone;3-O-benzyl-carvotacetone;anti-plasmodial;Cryptococcosis | en_US |
dc.title | Synthesis, structural assignments and antiinfective activities of 3-O-benzyl-carvotacetone and 3-hydroxy-2-isopropyl-5-methyl-p-benzoquinone | en_US |
dc.type | Article | en_US |